AEterna Zentaris presents results for AEZS-112 in advanced lymphoma and tumor AEterna Zentaris Inc.

AEterna Zentaris presents results for AEZS-112 in advanced lymphoma and tumor AEterna Zentaris Inc what is vardenafil . Provides presented a poster outlining Stage 1 results for its orally-active topoisomerase and tubulin II inhibitor compound, AEZS-112, in individuals with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic strategy for the treating cancer. The poster was presented at the American Association for Tumor Research Annual Interacting with in Denver, Colorado. The poster entitled, ‘Phase I dose-escalation, security, and pharmacokinetic study on weekly oral AEZS-112, a small molecule anti-cancers agent in individuals with advanced malignancy and lymphoma’, D.W.